Biden's Latest Move Just Handed the Vaccine Market to These 2 Companies

It's no secret that we need several companies' products to gain approval in order to meet worldwide demand for a coronavirus vaccine. Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) reached commercialization first when the U.S. Food and Drug Administration (FDA) granted their vaccine candidates Emergency Use Authorization (EUA) late last year. Johnson & Johnson (NYSE:JNJ), AstraZeneca (NASDAQ:AZN), and Novavax (NASDAQ:NVAX) are close behind. If each produced vaccines at top capacity, we still wouldn't have enough supply to immunize everyone worldwide. So, globally, there is plenty of business for all.